GSK1358820
GSK1358820 is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
6
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Efficacy and Safety Study of GSK1358820 in Japanese Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity
Efficacy and Safety of GSK1358820 in Subjects With Overactive Bladder
Study Of GSK1358820 In Patients With Post-Stroke Upper Limb Spasticity
Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Patients With Strabismus
GSK1358820 (Botulinum Toxin A) PhIII DB & OL Study in Patients With Axillary Hyperhidrosis
Clinical Trials (6)
Efficacy and Safety Study of GSK1358820 in Japanese Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity
Efficacy and Safety of GSK1358820 in Subjects With Overactive Bladder
Study Of GSK1358820 In Patients With Post-Stroke Upper Limb Spasticity
Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Patients With Strabismus
GSK1358820 (Botulinum Toxin A) PhIII DB & OL Study in Patients With Axillary Hyperhidrosis
Study of GSK1358820 In Patients With Post-Stroke Lower Limb Spasticity
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6